Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Tobramycin vs Placebo in Cystic Fibrosis Patients with Initial Pseudomonas aeruginosa Colonization
2007-003868-22Phase 3Active
- Sponsor
- Erempharma
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in cystic fibrosis (CF) and Pseudomonas aeruginosa airway infection comparing Inhaled Tobramycin with Placebo (2 arms). Primary endpoint: Change in Pseudomonas aeruginosa load in bronchial secretions. Started Dec 2007; status: active.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa airway infection
Beyond the preview
Go deeper on 2007-003868-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003868-22.